Dolphin Medical Services Share Price
6.63+0.02 (+0.30%)
+218.75% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Dolphin Medical Services Share Price
6.63+0.02 (+0.30%)
+218.75% past 1 Year
Technical meters

No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Dolphin Medical Services Share Price
6.63+0.02 (+0.30%)
+218.75% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly

No results found
Bulk & block deals

No results found
Insider trading & SAST

No results found
Dolphin Medical Services Share Price
6.63+0.02 (+0.30%)
+218.75% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Dolphin Medical Services Share Price
6.63+0.02 (+0.30%)
+218.75% past 1 Year
Corporate filings & documents

No corporate filings & documents found
Dolphin Medical Services Share Price
6.63+0.02 (+0.30%)
+218.75% past 1 Year
News
Larsen and Toubro Reports Rs 20.60 Crores NSE Block Trade
Equity
LT
Mercedes Challenges And Margin Pressure May Affect Motherson Earnings
Equity
TFCI reports Rs 30.92 crores BSE block trade involving 2,117,122 shares
Equity
TFCILTD
Anthem Biosciences Reports Rs 249.90 Crores BSE Block Trade
Equity
ANTHEM
India Ten Year Government Bond Yield Eases From Previous Close
Currency
Rupee Opens Higher Against Dollar After Previous Session Weak Close
Currency
TCS Sees Seasonal Q3 Furloughs as AI Revenue Crosses 10 Percent
Equity
TCS
TCS Maintains Long Term Margin Goal Despite Near Term Investment Pressure
Equity
TCS
TCS Expects International Growth And Seasonal Consumer Business Improvement
Equity
TCS
GST Council Proposes Five Percent Rate Option For Electric Passenger Transport Services
Broader Market
CDSCO Reviews Disposal Framework For Equipment From Closed Pharma Units
Broader Market
Highway Infra Secures Rs 24.46 Crore NHAI Toll Operations Contract
Equity
HILINFRA
Jefferies Sees Manageable Hospital Margin Impact From Cancer Drug Price Cap
Broader Market
Kotak Securities upgrades KEC International to Add with Rs 400 target
Equity
KEC
Goldman Sachs Sees Limited Earnings Impact From Anti Cancer Drug Margin Cap
Broader Market
US PERM Suspension Seen Having Limited Impact On Indian IT Firms
Broader Market
UBS Initiates Buy Rating On LG Electronics India With Rs 2,100 Target
Equity
LGEINDIA
UBS Maintains Buy Rating On Blue Star With Rs 2,000 Target Price
Equity
BLUESTARCO
Kotak Maintains Add On TCS After In Line Second Quarter Performance
Equity
TCS
CLSA Maintains Hold On TCS As Margin Recovery Remains Uncertain
Equity
TCS

